Integrated Biopharma Inc (INBP) financials · rev $43.9M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Integrated Biopharma Inc (INBP) rev $43.9M.
| Line | FY2026 | FY2025 |
|---|---|---|
| Revenue | $43.9M | $54.4M |
| Cost of Revenue | $43.1M | $48.8M |
| Gross Profit | $800.0K | $5.56M |
| Operating Income | -$2.71M | $2.02M |
| Net Income | -$2.84M | $808.0K |
| EPS (Diluted) | -$0.09 | $0.03 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $25.3M | $24.9M |
| Current Assets | $17.4M | $18.8M |
| Cash & Equivalents | $4.47M | $3.62M |
| Inventory | $9.14M | $9.36M |
| PP&E | $1.75M | $1.72M |
| Total Liabilities | $7.67M | $4.58M |
| Current Liabilities | $5.80M | $4.25M |
| Shareholders' Equity | $17.7M | $20.3M |
| Retained Earnings | -$34.3M | -$31.4M |
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | $1.24M | $2.06M |
| CapEx | $346.0K | $191.0K |
| Investing Cash Flow | -$340.0K | -$205.0K |
| Financing Cash Flow | -$45.0K | $78.0K |
| Net Change in Cash | $856.0K | $1.94M |
| Free Cash Flow | $895.0K | $1.87M |
FAQ
What is INBP P/E and revenue?
Integrated Biopharma Inc (INBP) rev $43.9M.
What is INBP revenue?
Integrated Biopharma Inc last cached revenue is $43.9M (FY2026).
Is INBP profitable?
Integrated Biopharma Inc last cached net income is -$2.84M (FY2026).
What are INBP total assets?
Integrated Biopharma Inc last cached total assets are $25.3M (FY2026).
What is INBP free cash flow?
Integrated Biopharma Inc last cached free cash flow is $895.0K (FY2026).
Not investment advice. Cached statements, not a live tape.